Schedule 13G ownership disclosure

THRESHOLD PHARMACEUTICALS INC

Security class unavailable · CUSIP: 885807206

Event date: 2015-02-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,150,000
Percent of class
5.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-15-012345
Form type
SC 13G
Filer
CAPITAL VENTURES INTERNATIONAL
CIK
CIK 1011712
Filed
Feb 20, 2015
Reporting period
Feb 11, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub